80 related articles for article (PubMed ID: 9409529)
1. Instability of the 12-nucleotide repeat in c-myb gene of bovine T-lymphoma cells.
Shinagawa T; Ishiguro N; Horiuchi M; Shinagawa M
J Vet Med Sci; 1997 Nov; 59(11):1071-4. PubMed ID: 9409529
[TBL] [Abstract][Full Text] [Related]
2. The proto-oncogene c-myb is expressed in sporadic bovine lymphoma, but not in enzootic bovine leukosis.
Asahina M; Ishiguro N; Wu D; Goryo M; Davis WC; Okada K
J Vet Med Sci; 1996 Dec; 58(12):1169-74. PubMed ID: 8996698
[TBL] [Abstract][Full Text] [Related]
3. Deletion of c-myb exon 9 induced by insertion of repeats.
Shinagawa T; Ishiguro N; Horiuchi M; Matsui T; Okada K; Shinagawa M
Oncogene; 1997 Jun; 14(23):2775-83. PubMed ID: 9190893
[TBL] [Abstract][Full Text] [Related]
4. A spontaneous internal deletion of the c-myb protooncogene enhances transcriptional activation in bovine T lymphoma cells.
Ishiguro N; Ohzono T; Shinagawa T; Horiuchi M; Shinagawa M
J Biol Chem; 1994 Oct; 269(43):26822-9. PubMed ID: 7929419
[TBL] [Abstract][Full Text] [Related]
5. Identification of an inducible regulator of c-myb expression during T-cell activation.
Phan SC; Feeley B; Withers D; Boxer LM
Mol Cell Biol; 1996 May; 16(5):2387-93. PubMed ID: 8628306
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.
Press RD; Reddy EP; Ewert DL
Mol Cell Biol; 1994 Apr; 14(4):2278-90. PubMed ID: 8139533
[TBL] [Abstract][Full Text] [Related]
7. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of B-cell lymphomas by avian leukosis virus.
Beemon KL; O'Reilly MM; Smith MR; Smith RE; Dunkel I; Hayward WS
Leukemia; 1997 Apr; 11 Suppl 3():179-82. PubMed ID: 9209336
[TBL] [Abstract][Full Text] [Related]
9. Potential transforming-ability by internal deletion of the bovine c-myb gene.
Ohozono T; Ishiguro N; Horiuchi M; Shinagawa M
J Vet Med Sci; 1996 Apr; 58(4):305-10. PubMed ID: 8741261
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
12. Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression.
Reddy CD; Reddy EP
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7326-30. PubMed ID: 2678098
[TBL] [Abstract][Full Text] [Related]
13. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes.
Reddy MA; Yang BS; Yue X; Barnett CJ; Ross IL; Sweet MJ; Hume DA; Ostrowski MC
J Exp Med; 1994 Dec; 180(6):2309-19. PubMed ID: 7964503
[TBL] [Abstract][Full Text] [Related]
14. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
Dasgupta P; Reddy EP
Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
16. Identification of a second promoter in the human c-myb proto-oncogene.
Jacobs SM; Gorse KM; Westin EH
Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
[TBL] [Abstract][Full Text] [Related]
17. Structure and biological activity of the transcriptional initiation sequences of the murine c-myb oncogene.
Sobieszczuk PW; Gonda TJ; Dunn AR
Nucleic Acids Res; 1989 Dec; 17(23):9593-611. PubMed ID: 2481264
[TBL] [Abstract][Full Text] [Related]
18. Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions.
Saikumar P; Murali R; Reddy EP
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8452-6. PubMed ID: 2236054
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression.
Sumitani K; Kamijo R; Nagumo M
Anticancer Res; 1997; 17(2A):865-71. PubMed ID: 9137419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
